Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Amyris Inc    AMRS

AMYRIS INC

(AMRS)
  Report  
SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector news

AMYRIS, INC. : Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant (form 8-K)

share with twitter share with LinkedIn share with facebook
share via e-mail
0
08/14/2019 | 05:03pm EDT

Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an

           Off-Balance Sheet Arrangement of a Registrant.



As previously reported, (i) on July 29, 2019, Amyris, Inc. (the "Company") entered into a Loan Agreement (the "Loan Agreement") with Nikko Chemicals Co., Ltd. ("Nikko"), the Company's partner with respect to its Aprinnova, LLC joint venture (the "JV"), to make available to the Company secured loans in an aggregate principal amount of $5.0 million (collectively, the "Loans"), and (ii) on July 30, 2019, the Company borrowed the first installment of $3.0 million under the Loan Agreement (the "First Installment"). The entry into the Loan Agreement, the terms of the Loans, the closing of the First Installment and related matters were reported in a Current Report on Form 8-K filed by the Company with the Securities and Exchange Commission on August 2, 2019, which is incorporated herein by reference.

On August 8, 2019, the Company and Nikko closed the remaining portion of the Loans (the "Second Closing"). At the Second Closing, the Company borrowed the remaining $2.0 million available under the Loan Agreement and received net cash proceeds of $1.9 million, with the remaining $0.1 million being withheld by Nikko as prepayment of the interest payable on such Loan through December 18, 2020.

© Edgar Online, source Glimpses

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on AMYRIS INC
08/14AMYRIS, INC. : Creation of a Direct Financial Obligation or an Obligation under ..
AQ
08/08AMYRIS : LAVVAN Appoints Neil Closner as Chief Executive Officer
BU
08/02AMYRIS, INC. : Entry into a Material Definitive Agreement, Creation of a Direct ..
AQ
08/01AMYRIS, INC. : Creation of a Direct Financial Obligation or an Obligation under ..
AQ
07/29AMYRIS, INC. : Shareholder Director Nominations, Other Events (form 8-K)
AQ
07/26AMYRIS : to Host Business Update Teleconference and Webcast on Monday, August 5,..
PR
07/25AMYRIS, INC. : Entry into a Material Definitive Agreement, Creation of a Direct ..
AQ
07/24AMYRIS, INC. : Entry into a Material Definitive Agreement (form 8-K)
AQ
07/19AMYRIS, INC. : Triggering Events That Accelerate or Increase a Direct Financial ..
AQ
07/19AMYRIS : ADL Bionatur Solutions and Amyris Expand Contract to 2020
PR
More news
Financials (USD)
Sales 2019 -
EBIT 2019 -
Net income 2019 -
Debt 2019 -
Yield 2019 -
P/E ratio 2019 -
P/E ratio 2020 -
Capi. / Sales2019 -
Capi. / Sales2020 -
Capitalization 454 M
Chart AMYRIS INC
Duration : Period :
Amyris Inc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends AMYRIS INC
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
 
Mean consensus -
Number of Analysts
Average target price
Last Close Price 4,41  $
Spread / Highest target -
Spread / Average Target -
Spread / Lowest Target -
EPS Revisions
Managers
NameTitle
John G. Melo President, Chief Executive Officer & Director
Geoffrey Mark Duyk Chairman
Eduardo Alvarez Chief Operating Officer
Kathleen Valiasek Chief Financial Officer
Joel Cherry President-Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
AMYRIS INC32.04%454
ECOLAB INC.41.55%59 510
HENKEL AG & CO. KGAA-8.81%39 244
GIVAUDAN14.15%24 438
SIKA AG10.55%18 142
EMS-CHEMIE HOLDING23.55%13 771